LOS ANGELES--(BUSINESS WIRE)--April 20, 2006--Abraxis BioScience, Inc. (NASDAQ:ABBI - News), an integrated, global biopharmaceutical company, today announced that the company’s senior management team will present a company overview at the UBS Global Specialty Pharmaceuticals Conference on Tuesday, April 25, 2006 at 10:00 a.m. EDT at the Grand Hyatt New York.
